Scholars@Duke
Chenyu Lin

Chenyu Lin

Assistant Professor of Medicine
Medicine, Hematologic Malignancies and Cellular Therapy
2400 Pratt Street, Suite 5000, Durham, NC 27705
ORCID iDhttps://orcid.org/0000-0002-4542-4232
2400 Pratt Street, Suite 5000, Durham, NC 27705

Academic Honors

H. Jean Khoury Award in Scholarly Excellence

National American Society of Transplantation and Cellular Therapy (ASTCT) · 2023

THRIVE Pre-CDA Pilot Award

National Department of Veterans Affairs · 2023

Clinical Research Training Course

National American Society of Transplantation and Cellular Therapy (ASTCT) · 2023

Methods in Clinical Cancer Research ("Vail" Workshop)

National American Society of Clinical Oncology · 2022

Young Investigator Award

National Society of Hematologic Oncology · 2022

Northwestern Emergency Medicine Teaching Award

Department Dept of Emergency Medicine · 2020

Northwestern Faculty Recognition for Exemplary Professionalism

Department Dept of Medicine · 2019

Northwestern Resident Teaching Award

Department Internal Medicine Residency Program · 2018

Pritzker School of Medicine Merit Scholarship

University University of Chicago · 2013

Yale Departmental Honors in Molecular Biophysics & Biochemistry

Department Yale University · 2012

Phi Beta Kappa

Scholarly Society Yale University · 2011

News Items

Published October 2, 2024
Pharmacy Times
Decitabine Demonstrates Therapeutic Potential for the Treatment of Myelofibrosis
Published August 5, 2024
U.S. Medicine
KRAS G12C in Veterans with NSCLC Has Favorable Outcomes Compared to Non-G12C Variants; Availability of Sotorasib Treatment Credited
Published May 29, 2023
U.S. Medicine
VA Demonstrates Success in Remote Treatment of Aggressive Cancers
Published April 26, 2023
Duke Cancer Institute
DCI-Led Clinical Trial Leads to FDA Approval of Novel Cord Blood Therapy
Published April 17, 2023
CGTlive
FDA Approves Omidubicel to Reduce Infection Risk in Patients With Hematologic Malignancies Undergoing Stem Cell Transplant
Published December 6, 2022
U.S. Medicine
VA Researchers Illuminate a New Blood Cancer, a Novel Type of CLL
Published October 5, 2022
VJHemOnc
SOHO 2022 | Long-term follow-up of allogeneic stem cell transplantation with omidubicel
Published October 2, 2022
Blood Cancers Today
Omidubicel Leads to 'Durable Long-Term Hematopoiesis'
Published October 1, 2022
CGT Live
Omidubicel Improves Survival in Hematologic Malignancies With HSCT
Published August 17, 2022
Targeted Oncology
Long-Term Follow Up Shows Potential of Omidubicel in Hematologic Malignancies
Published April 25, 2022
Bloomberg
Gamida Cell Announces Results of New Health Economic and Outcome Study Reporting Improved Health Equity and Health Outcomes With Omidubicel
Published November 4, 2021
Business Wire
Gamida Cell Announces Data to Be Presented at 63rd ASH Annual Meeting